Related Experiment Video
Updated: May 16, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
[Primary hyperaldosteronism in cats]
1Klinik für Kleintiermedizin und Veterinärmedizinisches Labor der Universität Zürich.
Schweizer Archiv Fur Tierheilkunde
|November 29, 2012
Summary
Primary hyperaldosteronism in cats can cause weakness, anorexia, and blindness. Surgical removal of affected adrenal glands (adrenalectomy) can normalize electrolyte levels and improve outcomes.
Area of Science:
- Veterinary Medicine
- Endocrinology
- Nephrology
Context:
- Primary hyperaldosteronism (PH) is a condition of excessive aldosterone secretion from the adrenal glands.
- This case series examines PH in feline patients presented to a veterinary hospital.
- The study spans a decade of clinical cases from 2002 to 2011.
Purpose:
- To describe the clinical presentation, diagnostic findings, and treatment outcomes of primary hyperaldosteronism in cats.
- To highlight the association between hypertension, hypokalemia, and ocular complications in affected felines.
- To evaluate the efficacy of unilateral adrenalectomy for managing feline PH.
Summary:
- Seven cats with primary hyperaldosteronism presented with symptoms including weakness, anorexia, cervical ventroflexion, and blindness.
- All cats exhibited hypokalemia; five had hypertension, with four showing retinal detachment and blindness.
- Ultrasonography revealed unilateral adrenomegaly in six cats. Aldosterone levels were elevated in four cats.
- Histopathology identified adrenal adenomas and carcinomas. Five cats underwent successful unilateral adrenalectomy, normalizing electrolytes.
Impact:
- This study provides valuable insights into the clinical manifestations and diagnostic approach for primary hyperaldosteronism in cats.
- It underscores the importance of monitoring blood pressure and electrolyte levels in cats with suspected adrenal gland disorders.
- Surgical intervention, specifically unilateral adrenalectomy, appears to be an effective treatment for primary hyperaldosteronism in felines, leading to positive clinical outcomes.
Related Concept Videos
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...